CN Stock MarketDetailed Quotes
002932 Wuhan Easy Diagnosis Biomedicine
Watchlist
24.01
-0.03-0.12%
Not Open 12/06 15:00 CST
24.30High23.85Low20.88KlotVolume
24.04Open24.04Pre Close50.21MTurnover1.34%Turnover Ratio10.83P/E (TTM)5.58BMarket Cap48.7452wk High1.33P/E (Static)232.52MShares20.9752wk Low0.92P/B3.74BFloat Cap59.77Historical High26.44Limit Up155.67MShs Float1.48Historical Low21.64Limit Down1.87%Amplitude9.89KlotAsk2.48Dividend TTM24.04Avg Price10.54KlotBid10.34%Div YieldTTM100Lot Size
Wuhan Easy Diagnosis Biomedicine Key Stats
EPS
According to the latest financial report of Wuhan Easy Diagnosis Biomedicine, the latest earnings per share (TTM) for the company is 0.63. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Wuhan Easy Diagnosis Biomedicine's latest financial report to see how much their book value per share (BVPS) is currently at 26.15.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Wuhan Easy Diagnosis Biomedicine shows that the company's current ratio is 3.61, indicating healthy liquidity.
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Wuhan Easy Diagnosis Biomedicine, the quick ratio is 3.53, indicating that the company can meet its short-term debt obligations.
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Wuhan Easy Diagnosis Biomedicine? The latest ROE figure is 2.31%, indicating that the company has stable profitability.
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Wuhan Easy Diagnosis Biomedicine, the total asset return on investment (ROA) is 2.16%.
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Wuhan Easy Diagnosis Biomedicine's latest financial report to see how their gross margin is doing - currently at 48.28%.
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Wuhan Easy Diagnosis Biomedicine, the net profit margin is 29.18%, which is a good sign for its profitability.
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.